The DST Gene Epidermolysis Bullosa Simplex Autosomal Recessive Type 2 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE. Priced at 4400 AED, this test is designed to detect mutations in the DST gene, which are responsible for the autosomal recessive form of Epidermolysis Bullosa Simplex (EBS) type 2. EBS is a group of genetic conditions that result in fragile skin that blisters easily from minor injuries or friction. The DST gene plays a critical role in the formation and function of the skin and other tissues, and mutations in this gene can lead to the symptoms associated with EBS.
This test is particularly important for individuals who have a family history of EBS or have symptoms suggestive of the condition. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the lab for the presence of genetic abnormalities in the DST gene. The results from this test can provide crucial information for diagnosis, allowing for appropriate management and care strategies to be implemented. Additionally, it can offer valuable insights for family planning decisions for those with a history of the condition. DNA Labs UAE provides this test with the aim of offering precise and reliable genetic testing services to help manage and understand hereditary conditions like EBS.
The "GRIN2A Gene Epilepsy with Neurodevelopmental Defects Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the GRIN2A gene, which have been linked to various forms of epilepsy accompanied by neurodevelopmental defects. This test is particularly crucial for individuals who exhibit symptoms of epilepsy along with cognitive, behavioral, or motor development issues, as it can provide a definitive genetic diagnosis. The GRIN2A gene plays a significant role in the functioning of NMDA receptors, which are vital for synaptic transmission and plasticity in the brain, influencing learning and memory. Mutations in this gene can disrupt these processes, leading to the aforementioned conditions.
The test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any abnormalities in the GRIN2A gene. The results can offer valuable insights into the specific type of epilepsy and neurodevelopmental disorder the individual might have, guiding treatment decisions and management strategies. It can also provide information on the risk of passing the condition to future offspring, which is crucial for family planning.
The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the GRIN2A gene. While the price might seem high, the potential benefits of obtaining a precise diagnosis and the consequent tailored treatment plan can be invaluable for affected individuals and their families. DNA Labs UAE is equipped with state-of-the-art facilities and employs experts in genetic testing, ensuring high-quality services and reliable results.
The GABRG2 gene is associated with a form of epilepsy known as childhood absence epilepsy type 2, a condition characterized by frequent, brief loss of consciousness and staring spells. This condition often starts in childhood and can significantly impact an individual's quality of life. The GABRG2 gene plays a crucial role in the functioning of GABA receptors, which are involved in inhibiting nerve transmission in the brain, and mutations in this gene can disrupt this process, leading to seizures.
DNA Labs UAE offers a specialized genetic test to identify mutations in the GABRG2 gene, which can be instrumental in diagnosing childhood absence epilepsy type 2. This test is particularly valuable for families with a history of this condition, providing them with crucial information that can guide treatment and management strategies. The test is priced at 4400 AED and involves a simple procedure, typically requiring only a blood sample or cheek swab from the patient.
By identifying specific genetic mutations associated with epilepsy, this test enables healthcare providers to offer a more personalized approach to treatment, potentially improving outcomes for affected individuals. It also offers families the opportunity to understand their risk of passing the condition onto future generations, aiding in informed family planning decisions.
The GABRA1 gene plays a crucial role in the normal functioning of the brain. Mutations in this gene are associated with several forms of epilepsy, including Childhood Absence Epilepsy Type 4 (CAE4), a condition characterized by frequent absence seizures that begin in childhood. These seizures involve brief episodes of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To identify susceptibility to CAE4, genetic testing for mutations in the GABRA1 gene is available. Conducted at DNA Labs UAE, this specialized test offers a comprehensive analysis of the GABRA1 gene to detect mutations that may predispose an individual to this form of epilepsy. The test is a critical tool for early diagnosis, allowing for timely intervention and management of the condition.
The cost of the GABRA1 gene epilepsy susceptibility test is 4400 AED. This investment covers the genetic analysis and the professional interpretation of results, providing valuable insights into the individual's genetic predisposition to CAE4. Early detection through this test can lead to better management strategies, potentially improving the quality of life for those affected by this condition.
The GABRB3 gene plays a crucial role in the development and function of the brain, particularly in the regulation of neurotransmission. Mutations in this gene have been linked to various neurological conditions, including Epilepsy Childhood Absence Type 5 (ECAT5). This specific type of epilepsy is characterized by frequent absence seizures that begin in childhood, significantly affecting attention and learning.
To diagnose and manage ECAT5 effectively, genetic testing for mutations in the GABRB3 gene is essential. DNA Labs UAE offers a comprehensive genetic test designed to identify mutations in the GABRB3 gene that are associated with Epilepsy Childhood Absence Type 5. This test is a valuable tool for clinicians in confirming the diagnosis, which can then guide treatment decisions and genetic counseling.
The cost of the GABRB3 gene epilepsy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the GABRB3 gene. The results of this test can provide crucial information for the effective management and treatment of individuals with ECAT5, offering them a better quality of life.
The CACNA1H gene plays a crucial role in the proper functioning of the body's cellular electrical signaling, which is essential for the normal operation of various physiological processes, including those in the brain. Mutations in the CACNA1H gene have been linked to epilepsy childhood absence type 6 (ECAT6), a specific form of epilepsy characterized by frequent, brief absence seizures that begin in childhood. These seizures involve short periods of staring and unresponsiveness, significantly impacting the child's quality of life and cognitive development.
To aid in the diagnosis and management of ECAT6, genetic testing for mutations in the CACNA1H gene is available. This test can confirm a diagnosis, help predict the course of the disease, and inform treatment decisions. Conducted at specialized facilities such as DNA Labs UAE, this genetic test involves analyzing the patient's DNA to identify mutations in the CACNA1H gene that are associated with the condition.
The cost of the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test at DNA Labs UAE is 4400 AED. This price may reflect the comprehensive nature of the testing process, which includes the collection of a DNA sample, usually through a blood draw or cheek swab, followed by sophisticated genetic analysis in the laboratory. The result from this test not only helps in confirming the diagnosis but also plays a critical role in the personalized treatment planning, offering a targeted approach based on the individual's genetic makeup.
In summary, the CACNA1H gene epilepsy childhood absence type 6 susceptibility genetic test is a valuable diagnostic tool offered at DNA Labs UAE, with the potential to significantly impact the management and treatment of affected individuals by providing precise genetic insights into their condition.
The DEPDC5 gene plays a significant role in the development of familial focal epilepsy with variable foci, a complex form of epilepsy characterized by seizures originating in different parts of the brain. This condition is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene is sufficient to increase the risk of developing epilepsy.
DNA Labs UAE offers a specialized genetic test to identify mutations in the DEPDC5 gene, providing essential information for families affected by this condition. The test is crucial for accurate diagnosis, understanding the risk of transmission to offspring, and guiding treatment decisions. The cost of the test is 4400 AED, making it a valuable investment for families seeking insights into their genetic predisposition to familial focal epilepsy with variable foci. This test is a step forward in personalized medicine, allowing for tailored treatment plans based on genetic makeup.
The LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, aimed at identifying mutations in the LGI1 gene that are associated with familial temporal lobe epilepsy type 1 (FTLE1). This condition is a form of epilepsy that typically affects families and is characterized by seizures originating in the temporal lobe of the brain. These seizures can manifest as sensory disturbances, emotional changes, or complex partial seizures that may progress to generalized tonic-clonic seizures.
The test involves collecting a DNA sample from the patient, usually through a blood draw or a cheek swab, which is then analyzed in the laboratory for specific genetic alterations in the LGI1 gene. Identifying mutations in this gene can confirm a diagnosis of FTLE1, which is crucial for tailoring treatment plans, managing symptoms more effectively, and providing genetic counseling for affected families.
The cost of the LGI1 Gene Epilepsy Familial Temporal Lobe Type 1 Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the comprehensive nature of the genetic analysis, the expertise required to interpret the results, and the potential life-changing impact that a precise diagnosis can have for patients and their families. It's an investment in understanding a genetic condition that affects not just the individual tested but can also have implications for their relatives, offering insights into inheritance patterns and risks for future generations.
The CPA6 gene epilepsy familial temporal lobe type 5 genetic test is a specialized diagnostic procedure aimed at identifying mutations in the CPA6 gene, which are associated with familial temporal lobe epilepsy type 5. This condition is a form of epilepsy characterized by seizures originating in the temporal lobes of the brain, often accompanied by sensory disturbances, emotional changes, or other neurological impairments.
DNA Labs UAE offers this comprehensive genetic test to individuals who have a family history of temporal lobe epilepsy or exhibit symptoms associated with the condition. By analyzing the DNA sample, usually obtained through a blood draw, the test can determine the presence of specific genetic alterations in the CPA6 gene that are linked to the disorder. This information is crucial for accurate diagnosis, informed family planning, and personalized treatment strategies.
The cost of the CPA6 gene epilepsy familial temporal lobe type 5 genetic test at DNA Labs UAE is 4400 AED. This investment includes the collection of the sample, genetic sequencing, and a detailed report of the findings. The report not only provides insights into the individual's genetic predisposition to familial temporal lobe epilepsy type 5 but also offers guidance on potential management and treatment options based on the genetic makeup.
The RELN Gene Epilepsy Familial Temporal Lobe Type 7 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to identify mutations in the RELN gene that are associated with Familial Temporal Lobe Epilepsy Type 7 (FTLE7). This condition is a form of epilepsy characterized by seizures originating in the temporal lobes of the brain, which can affect behavior, memory, and emotional control. The test aims to provide crucial genetic information that can aid in the precise diagnosis, management, and treatment planning for individuals and families affected by this condition. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and the detailed insights it offers into the genetic underpinnings of FTLE7. This test is particularly valuable for families with a history of temporal lobe epilepsy, offering them a clearer understanding of their genetic risk and potential preventive measures or targeted therapies.
